Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Srikanth Vallurupalli

Concepts (287)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Coronary Artery Disease
11
2022
321
4.020
 Why?
Atrial Fibrillation
5
2022
185
2.670
 Why?
Percutaneous Coronary Intervention
9
2022
335
2.590
 Why?
Ventricular Dysfunction, Right
3
2023
32
2.560
 Why?
Aortic Valve Stenosis
5
2021
75
2.370
 Why?
Ventricular Function, Right
5
2023
44
2.320
 Why?
Stents
8
2022
370
2.220
 Why?
Angioplasty, Balloon, Coronary
4
2018
159
2.150
 Why?
Echocardiography
11
2021
374
2.030
 Why?
Endocarditis
2
2022
30
1.500
 Why?
Aortic Valve
3
2020
113
1.480
 Why?
Thrombocytopenia
2
2022
98
1.440
 Why?
Treatment Outcome
25
2022
5645
1.310
 Why?
Myocardial Infarction
4
2022
424
1.300
 Why?
Fractional Flow Reserve, Myocardial
4
2022
142
1.230
 Why?
Heart Failure
6
2022
492
1.200
 Why?
Ischemic Attack, Transient
2
2018
58
1.190
 Why?
Humans
65
2023
53836
1.190
 Why?
Electrocardiography
5
2022
286
1.130
 Why?
Veterans
2
2022
622
1.050
 Why?
Stroke
3
2021
511
1.020
 Why?
Coronary Stenosis
2
2021
107
0.930
 Why?
Coronary Angiography
9
2022
390
0.900
 Why?
Risk Factors
16
2022
3958
0.880
 Why?
Endocarditis, Bacterial
1
2022
40
0.860
 Why?
Electric Countershock
1
2022
33
0.860
 Why?
Atrial Appendage
1
2021
19
0.830
 Why?
Anemia
1
2022
89
0.820
 Why?
Catheter Ablation
2
2021
131
0.810
 Why?
Anticholesteremic Agents
1
2021
36
0.810
 Why?
Pulmonary Artery
1
2022
150
0.800
 Why?
Hypercholesterolemia
1
2021
43
0.800
 Why?
Kidney Diseases
3
2021
291
0.790
 Why?
Cryosurgery
1
2021
37
0.780
 Why?
Systole
4
2023
77
0.770
 Why?
Magnetic Resonance Imaging, Cine
3
2016
65
0.760
 Why?
Operative Time
2
2017
78
0.750
 Why?
Dyspnea
3
2018
81
0.740
 Why?
Digitalis
1
2019
4
0.740
 Why?
Exercise Test
2
2022
138
0.730
 Why?
Heart
2
2021
352
0.720
 Why?
Anticoagulants
3
2022
268
0.710
 Why?
Retrospective Studies
15
2023
6330
0.710
 Why?
Predictive Value of Tests
10
2022
1057
0.700
 Why?
Male
31
2022
27633
0.690
 Why?
Thrombosis
2
2022
239
0.680
 Why?
Aged
20
2022
10151
0.670
 Why?
Cardiac Catheters
1
2018
13
0.660
 Why?
Auscultation
1
2018
9
0.660
 Why?
Heart Murmurs
1
2018
15
0.660
 Why?
Asymptomatic Diseases
1
2018
43
0.650
 Why?
Drug Prescriptions
1
2018
87
0.640
 Why?
Artifacts
1
2017
58
0.620
 Why?
Female
28
2022
28727
0.620
 Why?
Heart Diseases
2
2017
232
0.610
 Why?
Coronary Disease
2
2015
155
0.610
 Why?
Middle Aged
21
2020
13217
0.610
 Why?
Mediastinal Neoplasms
1
2017
20
0.600
 Why?
Peripheral Arterial Disease
1
2018
87
0.590
 Why?
Echocardiography, Doppler
1
2017
61
0.590
 Why?
Time Factors
9
2022
3282
0.590
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2018
150
0.590
 Why?
Coronary Occlusion
1
2017
80
0.580
 Why?
Hospital Mortality
2
2018
463
0.580
 Why?
Absorbable Implants
1
2016
16
0.580
 Why?
Surgical Procedures, Operative
1
2017
81
0.570
 Why?
Pneumonia
1
2017
129
0.560
 Why?
Acute Coronary Syndrome
1
2017
91
0.550
 Why?
Tomography, Optical Coherence
1
2017
149
0.550
 Why?
Propafenone
1
2015
2
0.550
 Why?
Tachycardia, Ectopic Atrial
1
2015
3
0.550
 Why?
Flecainide
1
2015
6
0.550
 Why?
Heart Conduction System
1
2015
24
0.540
 Why?
Hypoparathyroidism
1
2015
9
0.540
 Why?
Respiratory Insufficiency
1
2017
123
0.540
 Why?
Rhabdomyolysis
1
2015
13
0.540
 Why?
Hypocalcemia
1
2015
14
0.530
 Why?
Heart Rate
2
2021
350
0.510
 Why?
Clinical Competence
1
2018
452
0.510
 Why?
Cardiac Surgical Procedures
2
2017
318
0.500
 Why?
Heart Neoplasms
1
2014
31
0.490
 Why?
Fibroma
1
2014
42
0.490
 Why?
Thyroidectomy
1
2015
101
0.490
 Why?
Physician-Patient Relations
1
2015
154
0.490
 Why?
Ventricular Function, Left
4
2019
175
0.480
 Why?
Theophylline
1
2013
22
0.470
 Why?
Recurrence
4
2021
695
0.470
 Why?
Diabetes Mellitus, Type 2
4
2022
481
0.460
 Why?
Syncope
1
2013
31
0.460
 Why?
Physicians
1
2015
253
0.410
 Why?
Amyloidosis
3
2016
80
0.390
 Why?
Sulfonylurea Compounds
1
2010
2
0.380
 Why?
Octreotide
1
2010
16
0.380
 Why?
Benzocaine
1
2009
5
0.370
 Why?
Arkansas
6
2019
2158
0.370
 Why?
Ventricular Remodeling
3
2021
64
0.370
 Why?
Methemoglobinemia
1
2009
7
0.360
 Why?
Prognosis
5
2022
2115
0.360
 Why?
Head and Neck Neoplasms
1
2013
326
0.360
 Why?
Hypoglycemia
1
2010
61
0.360
 Why?
Echocardiography, Transesophageal
1
2009
73
0.350
 Why?
Anesthetics, Local
1
2009
75
0.350
 Why?
Diagnosis, Differential
3
2018
1139
0.340
 Why?
Stroke Volume
2
2019
138
0.340
 Why?
Prosthesis Design
3
2022
263
0.320
 Why?
Prospective Studies
3
2023
2569
0.320
 Why?
Vasodilator Agents
2
2022
108
0.320
 Why?
Myocardial Contraction
2
2019
114
0.320
 Why?
Incidence
5
2019
1074
0.310
 Why?
Coronary Vessels
2
2020
185
0.290
 Why?
Heart Ventricles
4
2022
268
0.290
 Why?
Pressure
2
2017
122
0.290
 Why?
Chronic Disease
3
2018
623
0.280
 Why?
Defibrillators, Implantable
2
2019
63
0.280
 Why?
Randomized Controlled Trials as Topic
5
2022
577
0.260
 Why?
Reproducibility of Results
2
2021
1306
0.260
 Why?
Cardiomyopathies
2
2016
111
0.260
 Why?
Foramen Ovale, Patent
2
2015
28
0.260
 Why?
Follow-Up Studies
5
2019
2376
0.250
 Why?
Hepatitis C, Chronic
2
2015
92
0.250
 Why?
Hospitalization
4
2022
687
0.230
 Why?
Bioprosthesis
1
2022
30
0.220
 Why?
Electrodes
1
2022
38
0.220
 Why?
Risk Assessment
4
2022
1375
0.220
 Why?
Proportional Hazards Models
3
2020
433
0.210
 Why?
Warfarin
1
2022
86
0.210
 Why?
Adult
8
2018
14303
0.210
 Why?
Multiple Myeloma
4
2017
2923
0.210
 Why?
Sodium-Glucose Transporter 1
1
2020
5
0.200
 Why?
Glycosides
1
2020
16
0.200
 Why?
Cardiac Catheterization
2
2022
240
0.200
 Why?
Microscopy, Fluorescence, Multiphoton
1
2020
8
0.200
 Why?
Pilot Projects
2
2022
815
0.200
 Why?
Heart Valve Prosthesis Implantation
1
2022
90
0.200
 Why?
Heart Valve Prosthesis
1
2022
93
0.200
 Why?
Vasodilation
1
2021
105
0.200
 Why?
Tachycardia, Supraventricular
1
2021
37
0.200
 Why?
Severity of Illness Index
2
2018
1087
0.200
 Why?
Cardiovascular System
1
2020
48
0.200
 Why?
Calcinosis
1
2020
58
0.190
 Why?
United States Department of Veterans Affairs
1
2022
318
0.190
 Why?
United States
3
2022
5162
0.190
 Why?
Digoxin
1
2019
23
0.180
 Why?
Heart Failure, Systolic
1
2019
7
0.180
 Why?
Blood Pressure
1
2022
575
0.180
 Why?
Electric Stimulation Therapy
1
2019
24
0.180
 Why?
Metoprolol
1
2019
13
0.170
 Why?
Inpatients
2
2018
209
0.170
 Why?
Cardiotonic Agents
1
2019
79
0.170
 Why?
Platelet Transfusion
1
2018
31
0.170
 Why?
Kaplan-Meier Estimate
2
2017
517
0.170
 Why?
Cerebrovascular Disorders
1
2018
54
0.170
 Why?
Hepatitis C Antibodies
2
2015
23
0.160
 Why?
Delivery of Health Care
1
2021
302
0.160
 Why?
Databases, Factual
2
2018
696
0.160
 Why?
Cardiac Imaging Techniques
1
2017
7
0.160
 Why?
Renal Insufficiency, Chronic
1
2020
177
0.160
 Why?
Cardiovascular Diseases
3
2020
477
0.160
 Why?
Cell Transdifferentiation
1
2017
7
0.150
 Why?
Fever
1
2018
126
0.150
 Why?
Xanthine Oxidase
1
2017
16
0.150
 Why?
Foam Cells
1
2017
16
0.150
 Why?
Hepacivirus
2
2015
127
0.150
 Why?
Logistic Models
2
2017
1002
0.150
 Why?
Hemorrhage
1
2018
192
0.150
 Why?
Respiratory Sounds
1
2017
54
0.150
 Why?
Myocytes, Smooth Muscle
1
2017
91
0.150
 Why?
Radiographic Image Enhancement
1
2016
31
0.150
 Why?
Survival Rate
2
2019
974
0.150
 Why?
Propensity Score
1
2017
136
0.150
 Why?
Inflammasomes
1
2017
61
0.150
 Why?
Gadolinium DTPA
1
2016
33
0.140
 Why?
Cohort Studies
2
2018
1548
0.140
 Why?
Chi-Square Distribution
1
2017
327
0.140
 Why?
Muscle, Smooth, Vascular
1
2017
140
0.140
 Why?
Quality Improvement
1
2018
238
0.140
 Why?
Voltage-Gated Sodium Channel Blockers
1
2015
8
0.140
 Why?
Intermittent Claudication
1
2015
12
0.140
 Why?
Ventricular Function
1
2015
19
0.140
 Why?
Fundoplication
1
2015
21
0.140
 Why?
Goiter
1
2015
6
0.140
 Why?
Healthcare Disparities
1
2018
259
0.140
 Why?
Pericardiectomy
1
2015
4
0.140
 Why?
Postpericardiotomy Syndrome
1
2015
4
0.140
 Why?
Immobilization
1
2015
14
0.130
 Why?
Supine Position
1
2015
34
0.130
 Why?
Kidney
1
2020
828
0.130
 Why?
Mucolipidoses
1
2014
4
0.130
 Why?
Pericarditis
1
2015
22
0.130
 Why?
Length of Stay
1
2018
693
0.130
 Why?
Colchicine
1
2015
36
0.130
 Why?
Secondary Prevention
1
2015
88
0.130
 Why?
Aged, 80 and over
3
2018
3506
0.130
 Why?
Scavenger Receptors, Class E
1
2017
219
0.130
 Why?
Thoracotomy
1
2014
38
0.120
 Why?
Obesity, Morbid
1
2015
88
0.120
 Why?
Sulfonamides
1
2015
151
0.120
 Why?
Septal Occluder Device
1
2014
29
0.120
 Why?
Carcinoma, Renal Cell
1
2015
122
0.120
 Why?
Pyrimidines
1
2015
199
0.120
 Why?
Bone Marrow Transplantation
1
2014
130
0.120
 Why?
Kidney Neoplasms
1
2015
198
0.120
 Why?
Laparoscopy
1
2015
184
0.120
 Why?
Administration, Oral
1
2013
468
0.110
 Why?
Tomography, X-Ray Computed
1
2017
1204
0.100
 Why?
Postoperative Complications
2
2015
1055
0.100
 Why?
Magnetic Resonance Imaging
2
2017
1640
0.100
 Why?
Injections, Subcutaneous
1
2010
60
0.090
 Why?
Pericardium
1
2010
28
0.090
 Why?
Gastrointestinal Agents
1
2010
38
0.090
 Why?
Drug Monitoring
1
2010
86
0.090
 Why?
Cause of Death
2
2020
154
0.090
 Why?
Quality of Life
1
2015
899
0.090
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
1049
0.090
 Why?
Lipid Metabolism
1
2010
204
0.080
 Why?
Renal Dialysis
1
2010
193
0.080
 Why?
Kidney Failure, Chronic
1
2010
225
0.080
 Why?
Dose-Response Relationship, Drug
1
2010
1518
0.070
 Why?
Exercise
1
2010
531
0.070
 Why?
Disease Progression
2
2020
911
0.070
 Why?
RNA, Viral
2
2015
140
0.060
 Why?
Oxidative Stress
1
2010
955
0.060
 Why?
Vitamin K
1
2022
17
0.060
 Why?
American Heart Association
1
2022
38
0.060
 Why?
Mitral Valve
1
2022
69
0.050
 Why?
Prosthesis Failure
1
2022
118
0.050
 Why?
Telemetry
1
2021
36
0.050
 Why?
Glucosides
1
2020
15
0.050
 Why?
Tachycardia
1
2021
32
0.050
 Why?
Diabetic Ketoacidosis
1
2020
17
0.050
 Why?
Platelet Aggregation Inhibitors
1
2022
177
0.050
 Why?
Acute Disease
1
2022
407
0.050
 Why?
Glomerular Filtration Rate
1
2020
139
0.050
 Why?
Early Diagnosis
1
2020
97
0.050
 Why?
Benzhydryl Compounds
1
2020
74
0.050
 Why?
Exercise Tolerance
1
2019
43
0.040
 Why?
Death, Sudden, Cardiac
1
2019
54
0.040
 Why?
Feasibility Studies
1
2020
401
0.040
 Why?
Anti-Arrhythmia Agents
1
2019
86
0.040
 Why?
Adrenergic beta-Antagonists
1
2019
104
0.040
 Why?
Oxygen Consumption
1
2019
229
0.040
 Why?
Recovery of Function
1
2019
224
0.040
 Why?
Uric Acid
1
2017
32
0.040
 Why?
Registries
1
2020
548
0.040
 Why?
Scavenger Receptors, Class A
1
2017
39
0.040
 Why?
Referral and Consultation
1
2018
313
0.040
 Why?
RNA Interference
1
2017
200
0.040
 Why?
Transfection
1
2017
417
0.040
 Why?
Hernia, Hiatal
1
2015
12
0.030
 Why?
Biopsy, Needle
1
2016
197
0.030
 Why?
ROC Curve
1
2016
262
0.030
 Why?
Gastroesophageal Reflux
1
2015
51
0.030
 Why?
Patient Acceptance of Health Care
1
2018
333
0.030
 Why?
Tubulin Modulators
1
2015
40
0.030
 Why?
Indazoles
1
2015
57
0.030
 Why?
Mice, Inbred C57BL
1
2020
2028
0.030
 Why?
Seroepidemiologic Studies
1
2014
53
0.030
 Why?
Disease Models, Animal
1
2020
1684
0.030
 Why?
Reactive Oxygen Species
1
2017
494
0.030
 Why?
Multivariate Analysis
1
2016
645
0.030
 Why?
Pneumonectomy
1
2014
27
0.030
 Why?
Survival Analysis
1
2016
746
0.030
 Why?
Biopsy
1
2016
679
0.030
 Why?
Prosthesis Implantation
1
2014
47
0.030
 Why?
Myocardium
1
2016
441
0.030
 Why?
Posture
1
2014
81
0.030
 Why?
Angiogenesis Inhibitors
1
2015
205
0.030
 Why?
Anti-Inflammatory Agents
1
2015
182
0.030
 Why?
Syndrome
1
2014
250
0.030
 Why?
Age Distribution
1
2013
206
0.030
 Why?
Ventricular Dysfunction, Left
1
2014
94
0.030
 Why?
Immunohistochemistry
1
2016
1109
0.030
 Why?
Polymerase Chain Reaction
1
2014
539
0.030
 Why?
Transplantation, Autologous
1
2014
452
0.030
 Why?
Cell Line, Tumor
1
2017
1546
0.030
 Why?
Comorbidity
1
2013
684
0.030
 Why?
Oxygen
1
2014
367
0.020
 Why?
alpha-2-HS-Glycoprotein
1
2010
1
0.020
 Why?
Thiobarbituric Acid Reactive Substances
1
2010
12
0.020
 Why?
Blood Proteins
1
2010
106
0.020
 Why?
Signal Transduction
1
2017
1793
0.020
 Why?
C-Reactive Protein
1
2010
151
0.020
 Why?
Interleukin-6
1
2010
313
0.020
 Why?
Lung Neoplasms
1
2014
620
0.020
 Why?
Animals
1
2020
14624
0.020
 Why?
Young Adult
1
2013
4356
0.010
 Why?
Adolescent
1
2013
6918
0.010
 Why?
Vallurupalli's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (287) concept(s)
_
Co-Authors Expand Description
See all (17) people
_
Similar People Expand Description
See all (18) people
_
Same Department Expand Description
Search Department